Literature DB >> 34155333

Metabolic adaption to extracellular pyruvate triggers biofilm formation in Clostridioides difficile.

Yannick D N Tremblay1,2, Benjamin A R Durand3,4, Audrey Hamiot3,5, Isabelle Martin-Verstraete3,6, Marine Oberkampf3, Marc Monot7, Bruno Dupuy8.   

Abstract

Clostridioides difficile infections are associated with gut microbiome dysbiosis and are the leading cause of hospital-acquired diarrhoea. The infectious process is strongly influenced by the microbiota and successful infection relies on the absence of specific microbiota-produced metabolites. Deoxycholate and short-chain fatty acids are microbiota-produced metabolites that limit the growth of C. difficile and protect the host against this infection. In a previous study, we showed that deoxycholate causes C. difficile to form strongly adherent biofilms after 48 h. Here, our objectives were to identify and characterize key molecules and events required for biofilm formation in the presence of deoxycholate. We applied time-course transcriptomics and genetics to identify sigma factors, metabolic processes and type IV pili that drive biofilm formation. These analyses revealed that extracellular pyruvate induces biofilm formation in the presence of deoxycholate. In the absence of deoxycholate, pyruvate supplementation was sufficient to induce biofilm formation in a process that was dependent on pyruvate uptake by the membrane protein CstA. In the context of the human gut, microbiota-generated pyruvate is a metabolite that limits pathogen colonization. Taken together our results suggest that pyruvate-induced biofilm formation might act as a key process driving C. difficile persistence in the gut.
© 2021. The Author(s), under exclusive licence to International Society for Microbial Ecology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34155333      PMCID: PMC8630010          DOI: 10.1038/s41396-021-01042-5

Source DB:  PubMed          Journal:  ISME J        ISSN: 1751-7362            Impact factor:   10.302


  60 in total

Review 1.  Microbe-microbe interactions during Clostridioides difficile infection.

Authors:  Arwa Abbas; Joseph P Zackular
Journal:  Curr Opin Microbiol       Date:  2020-02-20       Impact factor: 7.934

2.  The Clostridium difficile spo0A gene is a persistence and transmission factor.

Authors:  Laura J Deakin; Simon Clare; Robert P Fagan; Lisa F Dawson; Derek J Pickard; Michael R West; Brendan W Wren; Neil F Fairweather; Gordon Dougan; Trevor D Lawley
Journal:  Infect Immun       Date:  2012-05-21       Impact factor: 3.441

Review 3.  Clostridium difficile and One Health.

Authors:  S C Lim; D R Knight; T V Riley
Journal:  Clin Microbiol Infect       Date:  2019-11-01       Impact factor: 8.067

Review 4.  Understanding Clostridium difficile Colonization.

Authors:  Monique J T Crobach; Jonathan J Vernon; Vivian G Loo; Ling Yuan Kong; Séverine Péchiné; Mark H Wilcox; Ed J Kuijper
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

5.  Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile.

Authors:  Charlie G Buffie; Vanni Bucci; Richard R Stein; Peter T McKenney; Lilan Ling; Asia Gobourne; Daniel No; Hui Liu; Melissa Kinnebrew; Agnes Viale; Eric Littmann; Marcel R M van den Brink; Robert R Jenq; Ying Taur; Chris Sander; Justin R Cross; Nora C Toussaint; Joao B Xavier; Eric G Pamer
Journal:  Nature       Date:  2014-10-22       Impact factor: 49.962

6.  Functional Intestinal Bile Acid 7α-Dehydroxylation by Clostridium scindens Associated with Protection from Clostridium difficile Infection in a Gnotobiotic Mouse Model.

Authors:  Nicolas Studer; Lyne Desharnais; Markus Beutler; Sandrine Brugiroux; Miguel A Terrazos; Laure Menin; Christian M Schürch; Kathy D McCoy; Sarah A Kuehne; Nigel P Minton; Bärbel Stecher; Rizlan Bernier-Latmani; Siegfried Hapfelmeier
Journal:  Front Cell Infect Microbiol       Date:  2016-12-20       Impact factor: 5.293

7.  Rational design of a microbial consortium of mucosal sugar utilizers reduces Clostridiodes difficile colonization.

Authors:  Fátima C Pereira; Kenneth Wasmund; Iva Cobankovic; Nico Jehmlich; Craig W Herbold; Kang Soo Lee; Barbara Sziranyi; Cornelia Vesely; Thomas Decker; Roman Stocker; Benedikt Warth; Martin von Bergen; Michael Wagner; David Berry
Journal:  Nat Commun       Date:  2020-10-09       Impact factor: 14.919

8.  Entry of spores into intestinal epithelial cells contributes to recurrence of Clostridioides difficile infection.

Authors:  Pablo Castro-Córdova; Paola Mora-Uribe; Rodrigo Reyes-Ramírez; Glenda Cofré-Araneda; Josué Orozco-Aguilar; Christian Brito-Silva; María José Mendoza-León; Sarah A Kuehne; Nigel P Minton; Marjorie Pizarro-Guajardo; Daniel Paredes-Sabja
Journal:  Nat Commun       Date:  2021-02-18       Impact factor: 17.694

9.  Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota.

Authors:  Julie A K McDonald; Benjamin H Mullish; Alexandros Pechlivanis; Zhigang Liu; Jerusa Brignardello; Dina Kao; Elaine Holmes; Jia V Li; Thomas B Clarke; Mark R Thursz; Julian R Marchesi
Journal:  Gastroenterology       Date:  2018-07-17       Impact factor: 22.682

10.  Identification of Clostridioides difficile-Inhibiting Gut Commensals Using Culturomics, Phenotyping, and Combinatorial Community Assembly.

Authors:  Sudeep Ghimire; Chayan Roy; Supapit Wongkuna; Linto Antony; Abhijit Maji; Mitchel Chan Keena; Andrew Foley; Joy Scaria
Journal:  mSystems       Date:  2020-02-04       Impact factor: 6.496

View more
  5 in total

1.  Therapeutic Effects of Bifidobacterium breve YH68 in Combination with Vancomycin and Metronidazole in a Primary Clostridioides difficile-Infected Mouse Model.

Authors:  Jingpeng Yang; Hong Yang; Lingtong Meng
Journal:  Microbiol Spectr       Date:  2022-03-21

2.  Production of p-cresol by Decarboxylation of p-HPA by All Five Lineages of Clostridioides difficile Provides a Growth Advantage.

Authors:  Mark A Harrison; Harparkash Kaur; Brendan W Wren; Lisa F Dawson
Journal:  Front Cell Infect Microbiol       Date:  2021-10-29       Impact factor: 5.293

3.  Recognition of extracellular DNA by type IV pili promotes biofilm formation by Clostridioides difficile.

Authors:  Leslie A Ronish; Ben Sidner; Yafan Yu; Kurt H Piepenbrink
Journal:  J Biol Chem       Date:  2022-09-03       Impact factor: 5.486

4.  What's a Biofilm?-How the Choice of the Biofilm Model Impacts the Protein Inventory of Clostridioides difficile.

Authors:  Madita Brauer; Christian Lassek; Christian Hinze; Juliane Hoyer; Dörte Becher; Dieter Jahn; Susanne Sievers; Katharina Riedel
Journal:  Front Microbiol       Date:  2021-06-10       Impact factor: 5.640

5.  Novel Drivers of Virulence in Clostridioides difficile Identified via Context-Specific Metabolic Network Analysis.

Authors:  Matthew L Jenior; Jhansi L Leslie; Deborah A Powers; Elizabeth M Garrett; Kimberly A Walker; Mary E Dickenson; William A Petri; Rita Tamayo; Jason A Papin
Journal:  mSystems       Date:  2021-10-05       Impact factor: 7.324

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.